相关临床试验
0
0 进行中
药物批准
6
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
**4\. Indications** Etoricoxib is indicated for: - Symptomatic relief of osteoarthritis (OA), - Rheumatoid arthritis (RA), - Symptomatic relief of ankylosing spondylitis (AS), - Pain and signs of inflammation associated with acute gouty arthritis, - Treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’s overall risks, taking into consideration other available therapeutic options. (see Section 6 ‘Contraindications’ and Section 7 ‘Special warning and precautions for use’ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
**4\. Indications** Etoricoxib is indicated for: - Symptomatic relief of osteoarthritis (OA), - Rheumatoid arthritis (RA), - Symptomatic relief of ankylosing spondylitis (AS), - Pain and signs of inflammation associated with acute gouty arthritis, - Treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’s overall risks, taking into consideration other available therapeutic options. (see Section 6 ‘Contraindications’ and Section 7 ‘Special warning and precautions for use’ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
**4\. What Stadeltine Film-Coated Tablet 5mg is used for** Stadeltine Film-Coated Tablet 5mg is used to treat symptoms such as sneezing, a runny nose and watery eyes associated with allergic rhinitis (including persistent allergic rhinitis) and to relieve the rashes and itching of chronic urticaria.
**5\. Indications** Hypertension Treatment of essential hypertension. Chronic heart failure (CHF) Treatment of stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients of ≥ 70 years.
暂无资讯文章